Cancer Research

Can 212Pb-ADVC001 Transform Advanced Prostate Cancer Care?
Research & Development Can 212Pb-ADVC001 Transform Advanced Prostate Cancer Care?

While 177Lu-PSMA-617 has improved survival, many patients eventually see their cancer progress as the disease develops resistance to beta-particle radiation. This clinical hurdle has forced researchers to look beyond standard therapies toward the high-energy potential of alpha-emitting isotopes.

Mayo Clinic Study Shows CSF Liquid Biopsy Aids Brain Tumor Care
Tech & Innovation Mayo Clinic Study Shows CSF Liquid Biopsy Aids Brain Tumor Care

Leptomeningeal disease represents a particular diagnostic challenge where cancer spreads to the protective membranes and fluid surrounding the brain. This condition often presents a clinical puzzle, as the traditional tools used to visualize the central nervous system frequently struggle to provide

Cancer Trial Gains Bring New Questions for Everyday Care
Research & Development Cancer Trial Gains Bring New Questions for Everyday Care

Patients receiving Roche’s divarasib lived a median of roughly 18 months in a Phase 3 lung cancer trial, compared with about 12 months among those receiving Krazati or Lumakras. That finding, presented at the European Society for Medical Oncology meeting, sits alongside encouraging results for a

Can New Genetic Clues Explain Liver Disease and Cancer Risk?
Tech & Innovation Can New Genetic Clues Explain Liver Disease and Cancer Risk?

Researchers analyzing the DNA of UK Biobank participants found 60 independent genetic variants associated with liver triglyceride levels. This monumental effort, which utilized magnetic resonance imaging data from a cohort of 71,488 individuals of European descent, has fundamentally altered the

Programmable CAR-T Cells Eradicate Pediatric Brain Tumors
Research & Development Programmable CAR-T Cells Eradicate Pediatric Brain Tumors

The development of B-SYNC is an evolution of the 2021 E-SYNC model, moving from a rare mutant protein trigger to a more universal brain protein to help a broader range of patients. In the current landscape of pediatric medicine, few diagnoses carry as much weight as diffuse midline glioma, an

NeuroAttnFuseNet Achieves 99% Accuracy in Brain Tumor Diagnosis
Tech & Innovation NeuroAttnFuseNet Achieves 99% Accuracy in Brain Tumor Diagnosis

Advanced deep learning has reached a pivotal moment in medical imaging with the introduction of a dual-branch architecture that identifies brain tumors with exceptional precision. As of 2026, the medical community continues to face an overwhelming surge in diagnostic imaging data, placing an

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later